EDQM publishes New Chapter "Quality of Data" for Comments
Recommendation
12-14 November 2024
Barcelona, Spain
Data Governance and Auditing the Analytical Process from Sampling to Reportable Value
The draft of the new chapter "5.38. QUALITY OF DATA" has been published on the website of the EDQM (European Directorate for the Quality of Medicines & HealthCare) in the Pharmeuropa section and can be commented on until 31 December 2024, along with several other new drafts.
The draft of the new chapter refers to data that is generated, collected or used in the context of quality control and highlights its increasing importance in relation to the quality assessment of medicinal products. In particular, if this data is processed or read out using AI (artificial intelligence) and/or ML (machine learning), it is necessary to apply and guarantee a defined quality standard. To this end, the draft of the new chapter sets out specifications and definitions in six sections and several subsections.
You can view and comment on the draft of chapter "5.38. QUALITY OF DATA" on the Pharmeuropa website after registering once.
Related GMP News
16.10.2024US FDA Warning Letter: Lab Data Integrity issues
16.10.2024FDA Warning Letter: Component Testing, Validation, and Stability
16.10.2024USP Chapter <621> Chromatography: Notice of Intent to Revise
15.10.2024Pharmeuropa Text for Comment: HPTLC for Herbal Products
09.10.2024WHO Biowaiver Project Cycle VII (2025) and Results from Cycle VI (2024)